Related Experiment Video
Updated: Jan 15, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Double trouble: Mycoplasma pneumoniae and its unexpected complications
Ai Phi Thuy Ho1, Eirik Brekka Tjønnfjord2, Saad Aballi3
1Department of Cardiology, Ostfold County Hospital Kalnes, Sarpsborg 1714, Norway.
Background:
This case highlights a rare and life-threatening presentation of Mycoplasma pneumoniae infection, demonstrating its potential to cause severe systemic complications beyond the respiratory tract. While often considered a mild illness, M. pneumoniae can contribute to thrombotic events, cardiac arrhythmias, and organ infarctions-complications that are under-recognized in clinical practice.
Case Summary:
A 43-year-old man presented with cardiogenic shock caused by atrial flutter, resistant to rate-controlling medications, necessitating electrical cardioversion. Imaging revealed thrombi in both ventricles, with the left-sided thrombus posing a high embolic risk. A right-sided intracardiac mass initially suspected to be infective endocarditis was later confirmed as thrombus via computed tomography (CT) imaging, highlighting the role of advanced imaging in differential diagnosis. The patient also developed necrotizing pneumonia and splenic infarction. He was treated with antibiotics, anticoagulation, heart failure therapy, and scheduled follow-up. The aetiology of the biventricular thrombi remains unclear, likely multifactorial-either due to M. pneumoniae-induced hypercoagulability, biventricular dysfunction, or both.
Conclusion:
Physicians should be aware that M. pneumoniae is not always a benign infection. It can provoke severe cardiac and thrombotic complications, even in immunocompetent adults. Intracardiac thrombi, in particular, may be overlooked, and CT imaging can be an important diagnostic tool when endocarditis is suspected. Early recognition and aggressive multidisciplinary management are essential for improving outcomes in such complex presentations.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: